Stock Earnings

Question 1

What are Reviva Pharmaceuticals Holdings, Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ocular Therapeutix Inc has a total asset of $808, Net loss of $-265

Question 2

What are the key financial ratios for RVPHW?

Accepted Answer

Ocular Therapeutix Inc's Current ratio is 5.28, has a Net margin is -519.6, sales per share of $0.27.

Question 3

How is Reviva Pharmaceuticals Holdings, Inc.'s revenue broken down by segment or geography?

Accepted Answer

Ocular Therapeutix Inc largest revenue segment is Bioresorbable Hydrogel-based Formulation Technology, at a revenue of 63,461,000 in the most earnings release.For geography, United States is the primary market for Ocular Therapeutix Inc, at a revenue of 63,723,000.

Question 4

Is Reviva Pharmaceuticals Holdings, Inc. profitable?

Accepted Answer

no, according to the latest financial statements, Ocular Therapeutix Inc has a net loss of $-265

Question 5

Does Reviva Pharmaceuticals Holdings, Inc. have any liabilities?

Accepted Answer

yes, Ocular Therapeutix Inc has liability of 153

Question 6

How many outstanding shares for Reviva Pharmaceuticals Holdings, Inc.?

Accepted Answer

Ocular Therapeutix Inc has a total outstanding shares of 215.92

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	51	51	63	58	51	43
Revenue Growth (YoY)	-19%	-19%	9%	14%	19%	153%
Cost of Revenue	6	6	5	5	4	4
Gross Profit	45	45	58	53	46	39
Selling, General & Admin	118	118	102	74	72	67
Research & Development	197	197	127	61	53	50
Operating Expenses	315	315	229	135	125	117
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-265	-265	-193	-80	-71	-6
Income Tax Expense	--	--	0	--	--	--
Net Income	-265	-265	-193	-80	-71	-6
Net Income Growth	37%	37%	141%	13%	1,083%	-96%
Shares Outstanding (Diluted)	222.89	187.24	158.26	79.82	76.88	76.39
Shares Change (YoY)	33%	18%	98%	4%	1%	26%
EPS (Diluted)	-1.19	-1.42	-1.22	-1.01	-0.92	-0.09
EPS Growth	3%	16%	21%	10%	922%	-96%
Free Cash Flow	-216	-216	-135	-76	-63	-66
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	88.23%	88.23%	92.06%	91.37%	90.19%	90.69%
Operating Margin	-529.41%	-529.41%	-271.42%	-141.37%	-152.94%	-181.39%
Profit Margin	-519.6%	-519.6%	-306.34%	-137.93%	-139.21%	-13.95%
Free Cash Flow Margin	-423.52%	-423.52%	-214.28%	-131.03%	-123.52%	-153.48%
EBITDA	-266	-266	-168	-80	-76	-76
EBITDA Margin	-521.56%	-521.56%	-266.66%	-137.93%	-149.01%	-176.74%
D&A For EBITDA	4	4	3	2	2	2
EBIT	-270	-270	-171	-82	-78	-78
EBIT Margin	-529.41%	-529.41%	-271.42%	-141.37%	-152.94%	-181.39%
Effective Tax Rate	--	--	0%	--	--	--

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) Financial

RVPHW Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

RVPHW Income

Follow-Up Questions